StefanCP, KoehlerJW, MinogueTD. Targeted next-generation sequencing for the detection of ciprofloxacin resistance markers using molecular inversion probes. Sci. Rep., 2016; 6: 25904. DOI: 10.1038/ srep25904.
3.
LomanNJ, ConstantinidouC, ChristnerM, et al.A Culture-Independent Sequence-Based Metagenomics Approach to the Investigation of an Outbreak of Shiga-Toxigenic Escherichia coli O104:H4. JAMA, 2013; 309(14): 1502–1510. DOI:10.1001/jama.2013.3231.
4.
LefterovaMI, SuarezCJ, BanaeiN, PinskyBA. Next-Generation Sequencing for Infectious Disease Diagnosis and Management: A Report of the Association for Molecular Pathology. J. Mol. Diagn., 2015; 17(6): 623–634. DOI: 10.1016/j.jmoldx.2015.07.004.
5.
XieF, DuanZ, ZengW, et al.Clinical metagenomics assessments improve diagnosis and outcomes in community-acquired pneumonia. BMC Infect. Dis., 2021; 21(1): 352. DOI: 10.1186/s12879-021-06039-1.
6.
BlauwkampTA, ThairS, RosenMJ, et al.Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease. Nat. Microbiol., 2019; 4(4): 663–674. DOI:10.1038/s41564-018-0349-6.
JingC, ChenH, LiangY, et al.Clinical Evaluation of an Improved Metagenomic Next-Generation Sequencing Test for the Diagnosis of Bloodstream Infections. Clin. Chem., 2021; 67(8): 1133–1143. DOI: 10.1093/clinchem/hvab061.
9.
LiuD, ZhouH, XuT, et al.Multicenter assessment of shotgun metagenomics for pathogen detection. EBioMedicine, 2021; 74: 103649. DOI: 10.1016/j.ebiom.2021.103649.
